Management of obsessive-compulsive disorder with fluvoxamine extended release
Lídia Ordacgi1, Mauro V Mendlowicz2, Leonardo F Fontenelle11Anxiety and Depression Research Program, Institute of Psychiatry, Universidade Federal do Rio de Janeiro (IPUB/UFRJ), Rio de Janeiro, Brazil; 2Department of Psychiatry and Mental Health, Universidade Federal Fluminense (MSM-U...
Enregistré dans:
Auteurs principaux: | Lídia Ordacgi, Mauro V Mendlowicz, Leonardo F Fontenelle |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c830afc5584e40ed8896e5b09818c0cd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine
par: Michele Fornaro
Publié: (2010) -
Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach
par: Hasanpour H, et autres
Publié: (2019) -
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder
par: Hasanpour H, et autres
Publié: (2018) -
Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
par: Yamamoto H, et autres
Publié: (2012) -
Adenylate-cyclase activity in platelets of patients with obsessive-compulsive disorder
par: D Marazziti, S Baroni, et autres
Publié: (2009)